Archive for June 14th, 2012

RPTP late January 2013 likely PDUFA date. AEGR proposed offering

Jun 14, 2012 No Comments by

Raptor Pharmaceutical Corp.  (Nasdaq:RPTP) today that the FDA accepted its New Drug Application (“NDA”) for Cysteamine Bitartrate Delayed-release Capsules (RP103), for the potential treatment of nephropathic cystinosis. A standard 10-month review was issued. A PDUFA date was not issued but the company released a press release on March 30, 2012 that it had filed its […]

Daily News Read more